KONSTANZ, Germany & OSAKA, Japan–(BUSINESS WIRE)–Nov 29, 2016–Takeda Pharmaceutical Company Limited (TOKYO:4502) (“Takeda”) today announced that it will invest more than 100 Million Euros to build a new manufacturing plant for its dengue vaccine …
( read original story …)